SCN Celebrates 25 Years of Transforming Lives Through Regenerative Medicine
Congratulations to our friends at SCN on 25 years! READ MORE HERE
Canada’s Stem Cell Network Announces $33M to Advance Regenerative Medicine Research and Clinical Trials
SCN announces $13.5M in funding for 36 regenerative medicine research projects and clinical trials involving more than 240 researchers, clinicians, and trainees from across Canada, with more than $19.5M in support from national partners. Read More Here
TMM2024 Career Connect – Calling all Job Seekers!
Highly skilled and qualified personnel are in high demandfrom employers across the hot regenerative medicine sector. At TMM2024,delegates can connect with companies and principal investigators who willshowcase their organizations, labs, and projects at TMM2024 Career Connect,TMM’s career expo. TMM2024 Career Connect will take place at the HotelBonaventure, Montreal, on Monday, November 4, 3:35pm to 5:30pm. Career Connect is sponsored by Vertex Pharmaceuticals! Job seekers! Don’t miss this opportunity to makeconnections with company recruiters and build your network. Register for TMM2024 and attend Career Connect. REGISTER HERE
SBME Research Day 2024
Keynote Presentations: This year we are highlighting the research of two junior SBME’s faculty members: Drs. Calvin Kuo and Dena Shahriari. Trainee Talks: Select trainees will present their research in short Trainee Talks. Come support them as they develop their presentation and communication skills! Poster Session: There is such a diverse range of biomedical research excellence at SBME. Our Poster Session gives graduate BME students the chance to share their findings with the community. Lunch will be served! (Make sure to RSVP to reserve your lunch) Costume Contest: Inject a bit of fun into the day by participating in our costume contest. Get creative [...]
New GMP Facility to be constructed in 2024
Congratulations to Dr. Megan Levings and the rest of the CIEBH team on their recent funding announcement! A GMP facility in BC has been a long time coming and we are proud of our members for bringing investment for these much-needed facilities and resources to the province!
STEMCELL Technologies Announces Acquisition of Propagenix Inc.
“The acquisition of Propagenix is an important step in STEMCELL’s growth journey and an achievement for Canada’s biotechnology industry,” said Dr. Allen Eaves, President and CEO, STEMCELL. “Propagenix’s technology has the potential to contribute to big advancements in scientific research in both labs and clinical settings for the treatment of cancer, airway diseases, and other disorders, and we are thrilled to welcome its portfolio into STEMCELL’s product suite.” READ THE FULL ARTICLE
Stem Cell Network and Research Canada Co-Host Parliamentary Event on Regenerative Medicine
A link to the full article can be found HERE
Canada’s Stem Cell Network Makes Its Single Largest Investment in Regenerative Medicine Research
SCN announces $19.5M in funding for 32 regenerative medicine research projects and clinical trials involving more than 400 researchers, clinicians, and trainees from across Canada Read more here